GGrantIndex
Sort

82,697 grants matching vaccine development

Early and Reinfection in High Risk Women

$789,642
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R37 · FY2017 · AI

Early and Reinfection in High Risk Women

$789,642
Julie M Overbaugh · Fred Hutchinson Cancer Research Center · R37 · FY2019 · AI

Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring

$789,630
Richard B Pyles · Oak Crest Institute Of Science · U19 · FY2016 · AI

Research Capacity Core

$789,515
Micheler Ricardo Richardson · North Carolina Central University · U54 · FY2022 · MD

Targeting HIV-specific T cell differentiation programs to enhance post-treatment control of HIV

$789,468
Rachel Lena Rutishauser · University Of California, San Francisco · R01 · FY2025 · AI

TASK A04: EVALUATION OF THERAPEUTICS AND VACCINES IN MOUSE MODELS OF DENGUE VIRUS

$789,448
David Beasley · University Of Texas Med Br Galveston · N01 · FY2019 · AI

Innate-adaptive immune bridging in gravidity-dependent immunity against placental malaria: a multi-omics approach

$789,442
Prasanna Jagannathan · Stanford University · R01 · FY2025 · AI

Impact of Care Delivery and Therapeutic Changes on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias

$789,438
John Hsu · Massachusetts General Hospital · U01 · FY2025 · AG

Hepatitis C: Studies of Immunity and Pathogenesis

$789,384
Charles M. Rice · Rockefeller University · U19 · FY2007 · AI

Neisseria gonorrhoeae metal transporters that subvert nutritional immunity

$789,348
Cynthia Nau Cornelissen · Georgia State University · R01 · FY2025 · AI

Neisseria gonorrhoeae metal transporters that subvert nutritional immunity

$789,348
Cynthia Nau Cornelissen · Georgia State University · R01 · FY2023 · AI

Neisseria gonorrhoeae metal transporters that subvert nutritional immunity

$789,348
Cynthia Nau Cornelissen · Georgia State University · R01 · FY2024 · AI

Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface

$789,339
Mihai Luchian Azoitei · Duke University · R01 · FY2022 · AI

Research Capacity Core

$789,335
Micheler Ricardo Richardson · North Carolina Central University · U54 · FY2023 · MD

Molecular Analysis of Host Immune Response in Leprosy

$789,331
Robert L Modlin · University Of California Los Angeles · R01 · FY2025 · AI

CENTER FOR RECOMBINANT GAMETE CONTRACEPTIVE VACCINOGENS

$789,309
University Of Virginia Charlottesville · U54 · FY2002 · HD

Hepatitis C: Studies of Immunity and Pathogenesis

$789,280
Charles M. Rice · Rockefeller University · U19 · FY2006 · AI

Targeting RIPK3 in Flu-Associated Lung Injury

$789,265
Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2021 · AI

Micro Analytical Immunochemistry

$789,255
Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2023 · EB

LINKING ANTIGENIC & GENETIC VARIATION OF DENGUE TO INDIVIDUAL AND POPULATION RISK

$789,253
Derek A Cummings · Johns Hopkins University · R01 · FY2015 · AI

Longitudinal SARS-CoV-2 mRNA vaccine-induced mucosal, serological, and cellular immunity in children and human milk

$789,208
Pia S Pannaraj · University Of California, San Diego · R01 · FY2024 · AI

SARS-CoV-2 whole genome sequencing from large-scale campus testing and state-wide communities in NH

$789,189
Rick H Cote · University Of New Hampshire · P20 · FY2022 · GM

Development of a Vaccine for HIV-AIDS: Cellular Immunity

$789,184
Marjorie Guroff · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Microneedle-based immunization against pandemic influenza

$789,183
Mark R Prausnitz · Georgia Institute Of Technology · R01 · FY2009 · EB

Impact of the Intestinal Microbiome on HIV/SIV Vaccines

$789,065
Herbert W Virgin · Washington University · R01 · FY2018 · OD